Publications and communications of Jeremy Blavier

Maseko, S. B., Brammerloo, Y., Van Molle, I., Sogues, A., Martin, C., Gorgulla, C., Plant, E., Olivet, J., Blavier, J., Ntombela, T., Delvigne, F., Arthanari, H., El Hajj, H., Bazarbachi, A., Van Lint, C., Salehi-Ashtiani, K., Remaut, H., Ballet, S., Volkov, A. N., & Twizere, J.-C. (21 July 2023). Identification of small molecule antivirals against HTLV-1 by targeting the hDLG1-Tax-1 protein-protein interaction. Antiviral Research, 217, 105675. doi:10.1016/j.antiviral.2023.105675

Blavier, J. (2022). Towards new drugs for immunotherapy in cancer [Poster presentation]. 2022 Télévie seminar, Liège, Belgium.

Pillaiyar, T., Rosato, F., Wozniak, M., Blavier, J., Charles, M., Laschet, C., Kronenberger, T., Müller, C. E., & Hanson, J. (05 December 2021). Structure-activity relationships of agonists for the orphan G protein-coupled receptor GPR27. European Journal of Medicinal Chemistry, 225, 113777. doi:10.1016/j.ejmech.2021.113777